First Time Loading...

Sangamo Therapeutics Inc
NASDAQ:SGMO

Watchlist Manager
Sangamo Therapeutics Inc Logo
Sangamo Therapeutics Inc
NASDAQ:SGMO
Watchlist
Price: 0.6299 USD 0.83% Market Closed
Updated: Mar 28, 2024

Wall Street
Price Targets

SGMO Price Targets Summary
Sangamo Therapeutics Inc

Wall Street analysts forecast SGMO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SGMO is 3.23 USD with a low forecast of 1.01 USD and a high forecast of 8.4 USD.

Lowest
Price Target
1.01 USD
60% Upside
Average
Price Target
3.23 USD
413% Upside
Highest
Price Target
8.4 USD
1 234% Upside
Sangamo Therapeutics Inc Competitors:
Price Targets
HRTX
Heron Therapeutics Inc
150% Upside
ENLV
Enlivex Therapeutics Ltd
217% Upside
IRWD
Ironwood Pharmaceuticals Inc
107% Upside
HPHA
Heidelberg Pharma AG
196% Upside
688293
Shanghai OPM Biosciences Co Ltd
32% Upside
145020
Hugel Inc
10% Upside
1952
Everest Medicines Ltd
4% Upside
ORGO
Organogenesis Holdings Inc
79% Upside

Revenue
Forecast

Revenue Estimate
Sangamo Therapeutics Inc

For the last 8 years the compound annual growth rate for Sangamo Therapeutics Inc's revenue is 21%. The projected CAGR for the next 3 years is -26%.

21%
Past Growth
-26%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Sangamo Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

Net Income Estimate
Sangamo Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-49%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SGMO's stock price target?
Price Target
3.23 USD

According to Wall Street analysts, the average 1-year price target for SGMO is 3.23 USD with a low forecast of 1.01 USD and a high forecast of 8.4 USD.

What is Sangamo Therapeutics Inc's Revenue forecast?
Projected CAGR
-26%

For the last 8 years the compound annual growth rate for Sangamo Therapeutics Inc's revenue is 21%. The projected CAGR for the next 3 years is -26%.